InvestorsHub Logo
Followers 9
Posts 920
Boards Moderated 0
Alias Born 04/21/2014

Re: None

Tuesday, 12/12/2017 9:50:48 PM

Tuesday, December 12, 2017 9:50:48 PM

Post# of 37540
BIG_Announcement_OMHE_is_Diving_into_$36Billion_Pain_Management_GlobalMarket

Link To News

The first, which we can share now, is development in the sphere of a cannabinoid-based drug-development. In collaboration with Dr. Karyemaitre Aliffe, MD, Omni Health is finalizing a regulatory path to commercialization of a breakthrough, proprietary compound agent with the potential to treat chronic pain.



The global market for pain management will grow from nearly $36.1 Billion in 2017 to $52.0 Billion by 2022. Recent stringent regulations regarding the usage of opioids and a number of opioid pain drugs being pulled from the market create an additional opportunity to fill the void left by the withdrawal of these drugs. As such, there is a significant potential for cannabinoid biotherapeutics to truly seize the day in the treatment of chronic pain and other debilitating conditions.



Folks! OMHE will hit $1 soon.

Made Thousands into Millions..Now in Tens of Millions